These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23057398)

  • 21. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haloperidol update: 1975.
    Ayd FJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract]   [Full Text] [Related]  

  • 23. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic-induced extrapyramidal reactions: classification, description, and diagnosis.
    Tarsy D
    Clin Neuropharmacol; 1983; 6 Suppl 1():S9-26. PubMed ID: 6139168
    [No Abstract]   [Full Text] [Related]  

  • 25. Iatrogenic morbidity in patients taking depot fluphenazine.
    Jose C; Mallya A; Mehta D; Evenson R; Holland R
    Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects and complications of neuroleptics (110 hospitalizations in neurology)].
    Destee A; Montagne B; Rousseaux M; Petit H; Warot P
    Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug-induced movement disorders].
    Takahashi A; Murasaki M
    Nihon Rinsho; 1993 Nov; 51(11):2929-34. PubMed ID: 7903986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA; Casey DE
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract]   [Full Text] [Related]  

  • 30. Akathisia as EPS.
    Pearlman CA
    J Clin Psychiatry; 1993 Jul; 54(7):280. PubMed ID: 8101522
    [No Abstract]   [Full Text] [Related]  

  • 31. [Malignant neuroleptic syndrome].
    Courtine JC; Blot P
    Nouv Presse Med; 1981 May; 10(21):1749. PubMed ID: 6112732
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 34. Akathisia: a distressing complication of neuroleptic treatment.
    Szabadi E
    Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistent akathisia associated with early tardive dyskinesia.
    Barnes TR; Braude WM
    Postgrad Med J; 1984 May; 60(703):359-61. PubMed ID: 6146131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
    Schwartz M; Weller B; Erdreich M; Sharf B
    J Clin Psychiatry; 1995 May; 56(5):212. PubMed ID: 7737962
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
    Cancro R; Davis JM; Klawans H; Tancredi L
    J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic associated extrapyramidal symptoms.
    Maurer I; Zierz S; Möller HJ; Jerusalem F
    Br J Psychiatry; 1995 Oct; 167(4):551-2. PubMed ID: 8829733
    [No Abstract]   [Full Text] [Related]  

  • 39. Handedness as a risk factor for neuroleptic-induced movement disorders.
    Brown KW; White T; Anderson F; McGilp R
    Biol Psychiatry; 1992 Apr; 31(7):746-8. PubMed ID: 1350923
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.